Hangzhou Alltest Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,748	1,067	920.38	1,318	1,982	2,179
Trading Asset Securities	488.18	1,325	1,657	1,471	1,833	780.2
Cash & Short-Term Investments	2,236	2,392	2,578	2,789	3,815	2,960
Cash Growth	-12.23%	-7.20%	-7.57%	-26.89%	28.90%	322.40%
Accounts Receivable	151.32	159.05	125.12	100.87	138.66	208.2
Other Receivables	6.38	5.98	6.67	8.18	10.35	67.4
Receivables	157.7	165.03	131.79	109.05	149.02	275.6
Inventory	184.96	176.69	160.32	188.59	193.66	383.84
Prepaid Expenses	-	1.35	0.71	11.65	2.15	8.19
Other Current Assets	113.16	96.54	94.75	63.24	29.63	41.03
Total Current Assets	2,692	2,832	2,965	3,161	4,189	3,668
Property, Plant & Equipment	1,024	1,018	903.44	759.8	317.14	223.62
Long-Term Investments	116.58	145.05	128.67	22.95	12.2	54.32
Other Intangible Assets	135.29	136.82	104.97	110.43	93.03	28.12
Long-Term Deferred Tax Assets	20.16	22.05	22.2	30.18	46.44	3.82
Long-Term Deferred Charges	14.91	16.49	10.35	15.72	17.88	5.66
Other Long-Term Assets	105.97	72.58	51.1	15.53	18.96	24.62
Total Assets	4,109	4,242	4,186	4,116	4,695	4,008
Accounts Payable	79.19	120.05	104.8	77.61	171.17	360.65
Accrued Expenses	11.8	31.68	32.41	33.16	73.51	44.61
Current Portion of Leases	0.54	0.54	2.34	16.26	8.32	20.06
Current Income Taxes Payable	77.04	76.3	86.43	73.96	73.26	61.71
Current Unearned Revenue	33.58	35.02	40.84	41.62	147.2	226.27
Other Current Liabilities	15.69	23.04	32.37	31.56	37.29	0.91
Total Current Liabilities	217.83	286.64	299.19	274.16	510.75	714.2
Long-Term Leases	6.81	6.87	1.76	7.66	13.44	17.3
Long-Term Unearned Revenue	2.14	2.57	1.64	2.68	-	-
Long-Term Deferred Tax Liabilities	-	-	0.01	-	-	3.2
Total Liabilities	226.79	296.09	302.6	284.5	524.2	734.71
Common Stock	79.28	79.28	79.28	79.28	53.9	53.9
Additional Paid-In Capital	1,683	1,680	1,708	1,713	1,744	1,733
Retained Earnings	2,222	2,202	2,177	2,107	2,455	1,487
Treasury Stock	-133.31	-47.41	-113.01	-103.4	-115.56	-
Comprehensive Income & Other	32.46	32.17	32.5	30.75	28.39	0.26
Total Common Equity	3,883	3,947	3,884	3,827	4,166	3,274
Minority Interest	-0.62	-0.35	-0.22	4.31	4.4	-
Shareholders' Equity	3,882	3,946	3,883	3,832	4,171	3,274
Total Liabilities & Equity	4,109	4,242	4,186	4,116	4,695	4,008
Total Debt	7.35	7.41	4.1	23.91	21.77	37.36
Net Cash (Debt)	2,229	2,385	2,574	2,765	3,793	2,922
Net Cash Growth	-12.38%	-7.34%	-6.92%	-27.10%	29.80%	317.07%
Net Cash Per Share	28.02	30.11	32.50	34.91	47.86	39.07
Filing Date Shares Outstanding	77.38	77.38	77.87	77.53	78.24	79.78
Total Common Shares Outstanding	77.38	78.69	77.87	78.16	78.24	79.78
Working Capital	2,474	2,545	2,666	2,887	3,678	2,954
Book Value Per Share	50.18	50.16	49.87	48.97	53.25	41.03
Tangible Book Value	3,748	3,810	3,779	3,717	4,073	3,246
Tangible Book Value Per Share	48.43	48.42	48.53	47.56	52.06	40.68
Buildings	-	986.16	403.78	194.44	198.85	58.13
Machinery	-	126.29	117.42	113.61	91.69	58.93
Construction In Progress	-	15.34	459.92	488.25	42.3	82.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.